R-Tech Ueno completes RK-023 phase I study on hypotrichosis of the eyelashes
R-Tech Ueno is pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.